PFBT
IMCR icon

Parkside Financial Bank & Trust’s Immunocore IMCR Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50
Closed -$3.42K – 2061
2023
Q4 		$3.42K Hold
50
– – ﹤0.01% 1396
2023
Q3 		$2.6K Hold
50
– – ﹤0.01% 1582
2023
Q2 		$3K Buy
+50
New +$2.85K ﹤0.01% 1553

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Parkside Financial Bank & Trust's IMCR Position: Q1 2024 in Review

Parkside Financial Bank & Trust sold out of Immunocore (IMCR) in Q1 2024, closing a stake of 50 shares — an estimated $3.42K sold.

Parkside Financial Bank & Trust first reported a position in IMCR in Q2 2023 and held it in 3 quarters. The position peaked at $3.42K in Q4 2023. 149 funds tracked by Wall St. Rank hold IMCR as of Q1 2024.

  • Parkside Financial Bank & Trust reported no remaining Immunocore position as of Q1 2024 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 50 Immunocore shares in Q1 2024, an estimated $3.42K.
  • Parkside Financial Bank & Trust first reported a position in Immunocore in Q2 2023 and held it in 3 quarters.
  • Parkside Financial Bank & Trust's Immunocore position peaked at $3.42K in Q4 2023.
  • 149 funds tracked by Wall St. Rank held Immunocore as of Q1 2024.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2024, filed 1 May 2024.